Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: April 30, 2015
Event: Announcement of an agreement in principle to settle administrative and civil claims with the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) regarding suspicious order reporting practices for controlled substances.
Key Financial Metrics
Settlement Cost: $150 million (agreed payment).
Accounting Treatment: The $150 million was accrued prior to the end of fiscal year 2015 (ended March 31, 2015). The amount is recorded on a pre- and post-tax basis.
Adjusted Earnings: The $150 million charge will be excluded from the calculation of FY 2015 Adjusted Earnings.
Other Metrics: The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the current period.
Material Changes and Operational Impact
The settlement involves significant operational restrictions in addition to the financial penalty:
- Aurora, Colorado: DEA registration suspended for all controlled substances for three years.
- Livonia, Michigan: DEA registration suspended for all controlled substances for two years.
- Washington Courthouse, Ohio: DEA registration suspended for all controlled substances for two years (commencing after the Livonia suspension ends).
- Lakeland, Florida: DEA registration suspended for hydromorphone products for one year.
Continuity of Operations: The Company expects no supply disruption to customers. Shipments will be rerouted from other distribution centers. Exceptions exist for customers under the pharmaceutical prime vendor contract with the Department of Veterans Affairs, who may continue to receive shipments from the suspended centers.
Guidance, Outlook, and Risks
Contingencies: The global settlement is subject to the execution of final settlement agreements.
Management Commentary: The Company stated that the suspensions will not result in supply disruptions.
Risks: The filing addresses the resolution of previously disclosed investigations into suspicious order reporting practices. The primary risk was the potential for civil and administrative claims, which is now being resolved via the $150 million settlement and operational suspensions.
Investor Verification Checklist
- Verify the execution of final settlement agreements with the DEA and DOJ.
- Confirm the impact of the $150 million charge on FY 2015 GAAP net income versus Adjusted Earnings.
- Monitor operational logistics to ensure no supply disruptions occur during the distribution center suspensions.
- Review the specific remedial measures the Company agreed to implement as part of the settlement.